Boron-Pleuromutilins as Anti-<i>Wolbachia</i> Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis
作者:Robert T. Jacobs、Christopher S. Lunde、Yvonne R. Freund、Vincent Hernandez、Xianfeng Li、Yi Xia、David S. Carter、Pamela W. Berry、Jason Halladay、Fernando Rock、Rianna Stefanakis、Eric Easom、Jacob J. Plattner、Louise Ford、Kelly L. Johnston、Darren A. N. Cook、Rachel Clare、Andrew Cassidy、Laura Myhill、Hayley Tyrer、Joanne Gamble、Ana F. Guimaraes、Andrew Steven、Franziska Lenz、Alexandra Ehrens、Stefan J. Frohberger、Marianne Koschel、Achim Hoerauf、Marc P. Hübner、Case W. McNamara、Malina A. Bakowski、Joseph D. Turner、Mark J. Taylor、Stephen A. Ward
DOI:10.1021/acs.jmedchem.8b01854
日期:2019.3.14
A series of pleuromutilins modified by introduction of a boron-containing heterocycle on C(14) of the polycyclic core are described. These analogs were found to be potent anti-Wolbachia antibiotics and, as such, may be useful in the treatment of filarial infections caused by Onchocerca volvulus, resulting in Onchocerciasis or river blindness, or Wuchereria bancrofti and Brugia malayi and related parasitic nematodes resulting in lymphatic filariasis. These two important neglected tropical diseases disproportionately impact patients in the developing world. The lead preclinical candidate compound containing 7-fluoro-6-oxybenzoxaborole (15, AN11251) was shown to have good in vitro anti-Wolbachia activity and physicochemical and pharmacokinetic properties providing high exposure in plasma. The lead was effective in reducing the Wolbachia load in filarial worms following oral administration to mice.
[EN] 1 -HYDROXY-BENZOOXABOROLES AS ANTIPARASITIC AGENTS<br/>[FR] 1-HYDROXY-BENZOOXABOROLES COMME AGENTS ANTIPARASITAIRES
申请人:LILLY CO ELI
公开号:WO2014149793A1
公开(公告)日:2014-09-25
Provided are compounds useful for controlling endoparasites both in animals and agriculture. Further provided are methods for controlling endoparasite infestations of an animal by administering an effective amount of a compound as described above, or a pharmaceutically acceptable salt thereof, to an animal, as well as formulations for controlling endoparasite infestations using the compounds described above or an acceptable salt thereof, and an acceptable carrier. The claimed compounds are described by the following Markush formula:A typical example for a compound according to above formula is: A typical example for a compound according to above formula is: